80
Participants
Start Date
September 30, 2005
Primary Completion Date
April 30, 2008
Study Completion Date
October 31, 2008
Single dose-group A
PF-00547659, single iv dose
Single dose-group A
PF-00547659, single iv dose
Multiple dose- Group B
PF-00547659, multiple dose
Single dose-group A
PF-00547659, single iv dose
Multiple dose- Group B
PF-00547659, multiple dose
Single dose-group A
PF-00547659, single dose
Single dose-group A
PF-00547659, single dose
Single dose-group A
PF-00547659, single dose
Single dose-group A
PF-00547659, single dose
Multiple dose-Group B
PF-00547659, multiple dose
Multiple dose- Group B
PF-00547659, multiple dose
Multiple dose- Group B
PF-00547659, multiple dose
Multiple dose- Group B
PF-00547659, multiple dose
Multiple dose- Group B
PF-00547659, multiple dose
Multiple dose-Group B
PF-00547659, multiple dose
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Leuven
Pfizer Investigational Site, Aarhus C
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Kiel
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Majadahonda
Pfizer Investigational Site, Münster
Pfizer Investigational Site, Regensburg
Pfizer Investigational Site, Brussels
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Nitra
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, L'hospitalet DEL Llobregat
Lead Sponsor
Pfizer
INDUSTRY